Global Topical Use Acne Treatment Market, By Type (Inflammatory Acne, Cystic Acne, Post-Surgical/Wound Acne), Treatment (Medication, Therapeutic Devices), Drug (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), Device (Laser, Others), Administration (Oral, Topical), End User (Hospitals, Clinics) - Industry Trends and Forecast to 2030.
Topical Use Acne Treatment Market Analysis and Size
The global topical use acne treatment market is experiencing robust growth driven by several key factors. One of the primary drivers is the escalating prevalence of acne-related skin issues among adolescents and adults worldwide. Factors such as hormonal imbalances, pollution, and unhealthy lifestyles contribute to the increasing incidence of acne, necessitating effective topical treatments. Technological advancements in dermatological research have led to the development of innovative and targeted therapies, enhancing the efficacy of topical treatments. In addition, the growing awareness about skincare and the availability of a wide range of topical acne treatments are encouraging consumers to seek these solutions. Rising disposable incomes in developing countries enable more individuals to afford acne treatments, further propelling market growth. Moreover, the preference for non-invasive and minimally invasive treatments has increased, with topical solutions being a convenient and widely accepted choice.
Data Bridge Market Research analyzes that the global topical use acne treatment market which was USD 6.68 billion in 2022, would rocket up to USD 13.91 billion by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. The “Medication” segment is expected to dominate the treatment segment of the market owing to an increase in the prevalence of acne diseases.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Topical Use Acne Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Inflammatory Acne, Cystic Acne, Post-Surgical/Wound Acne), Treatment (Medication, Therapeutic Devices), Drug (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), Device (Laser, Others), Administration (Oral, Topical), End User (Hospitals, Clinics)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, Brazil, Argentina, Peru, and Rest of South America
|
|
Market Players Covered
|
Vyne Therapeutics Inc. (U.S.), Galderma laboratories (U.S.), Allergan (Ireland), Bayer AG (Germany), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), GlaxoSmithKline plc (U.K.), Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer AG (Germany), Dermira (U.S.), GUTHY|RENKER (U.S.), Reckitt Benckiser Group plc (U.K.), and ALLERGAN (Ireland)
|
|
Market Opportunities
|
|
Market Definition
Acne or acne vulgaris is known to be one of the most common skin conditions, especially among adolescents. This type of skin condition is generally caused by skin structures. This condition is characterized by blackheads, scarring, pimples, and oily skin.
Global Topical Use Acne Treatment Market Dynamics
Drivers
- Rising Prevalence of Acne
The global prevalence of acne-related skin conditions among adolescents and adults is a significant factor driving the market growth. Factors such as hormonal changes, unhealthy lifestyles, and pollution contribute to the increasing incidences of acne, necessitating effective topical treatments.
- Technological Advancements in Dermatological Research
Ongoing advancements in dermatological research have led to the development of innovative topical treatments. Novel formulations, targeted therapies, and personalized treatments are driving the market forward.
- Increasing Awareness about Skincare
Growing awareness about skincare and the availability of a wide range of topical acne treatments contribute to the market growth. Educational campaigns and social media awareness further drive consumer interest in seeking treatment for skin-related issues.
- Economic Growth in Developing Countries
Improving economic conditions in emerging markets increase disposable income, enabling more people to afford acne treatments, including topical solutions.
Opportunities
- Innovative Formulations
Continued R&D of advanced formulations, such as combination therapies, natural ingredients, and customized treatments, offer growth opportunities. Products catering to specific skin types and ethnicities create niche markets.
- Telemedicine and E-commerce
The rise of telemedicine and online pharmacies expands market reach. E-commerce platforms enable the easy availability of topical treatments, especially in regions with limited access to dermatological clinics.
Restraints/Challenges
- Side Effects and Skin Sensitivity
Some topical treatments can cause skin irritation, redness, or dryness, limiting their usability. Patient-specific skin sensitivities pose a challenge for manufacturers to develop universally applicable products.
- Regulatory Challenges
Stringent regulations related to the approval and commercialization of topical treatments hinder market growth. Meeting regulatory requirements and ensuring product safety and efficacy is a constant challenge for companies.
- Competition from Oral Medications
Oral medications, including antibiotics and hormonal treatments, pose a competitive challenge to topical treatments. The choice between oral and topical solutions creates market competition, affecting sales.
- Availability of Over-the-Counter Products
Over-the-counter (OTC) topical acne treatments are readily available, impacting prescription-based products. Consumer inclination towards self-medication affects the prescription-based topical treatment market.
The global topical use acne treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on this market, contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In June 2021, Almirall announced the launch of Seysara. The product is a novel tetracycline-derived oral antibiotic. It is known to be developed specifically for treating acne and is commercially launched in the U.S. market
- In January 2022, GALDERMA stated that it had gained authorization from the U.S. authorities. It had finished ALASTIN Skincare's duties for the production of clinically tested items that were created and distributed by physicians themselves
- In June 2020, Bausch Health Companies Inc. introduced ARAZLO lotion for patients above the age of nine who had an eruption on the skin which fell under the heading of acne vulgaris. This took place in the U.S.
- In March 2020, COSMEDIX, which is a leading manufacturer in the market of skincare products, disclosed a new product that possessed the capacity to relieve acne rapidly
Global Topical Use Acne Treatment Market Scope
The global topical use acne treatment market is segmented on the basis of type, treatment, drug, device, administration, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Inflammatory Acne
- Cystic Acne
- Post-Surgical/Wound Acne
Treatment
- Medication
- Therapeutic Devices
Drug
- Antibiotics
- Anti-Inflammatory Drugs
- Antimicrobial
- Combination Medications
- Hormonal Agents
- Oral Retinoid
- Topical Retinoid
Device
- Laser
- Others
Administration
- Oral
- Topical
End User
- Hospitals
- Clinics
Global Topical Use Acne Treatment Market Regional Analysis/Insights
The global topical use acne treatment market is analyzed and market size insights and trends are provided by country, type, treatment, drug, device, administration, and end user as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the developments related to acne therapeutics within the region.
Asia-Pacific is expected to be the fastest-growing region during the forecast period of 2023 to 2030 due to the high demand for acne therapeutics in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global topical use acne treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2011-2021.
Competitive Landscape and Global Topical Use Acne Treatment Market Share Analysis
The global topical use acne treatment market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global topical use acne treatment market are
- Vyne Therapeutics Inc. (U.S.)
- Galderma laboratories (U.S.)
- Allergan (Ireland)
- Bayer AG (Germany)
- Bausch Health Companies Inc. (Canada)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Johnson & Johnson Services, Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Bayer AG (Germany)
- Dermira (U.S.)
- GUTHY|RENKER (U.S.)
- Reckitt Benckiser Group plc (U.K.)
- ALLERGAN (Ireland)
SKU-